From the interview; it sounds like $2-3 is fair value sometime between testing being completed on RC220 and the P1a/b trial starting. Value from that point forward relates to results from said trial(s)
I'd personally be happy to see us sitting between two and three dollars in the next few months as we lead intro trials.
From the interview; it sounds like $2-3 is fair value sometime...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.045(2.80%) |
Mkt cap ! $260.3M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.55 | $94.33K | 60.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1250 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 5000 | 1 |
View Market Depth
| Last trade - 14.37pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.56 |
Change
-0.045 ( 1.17 %) |
||||
| Open | High | Low | Volume | ||
| $1.58 | $1.59 | $1.55 | 8174 | ||
| Last updated 14.21pm 16/05/2024 ? | |||||
| RAC (ASX) Chart |